1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East and Africa Neurological Biomarker Market – By Product

1.3.2        Middle East and Africa Neurological Biomarker Market – By Application

1.3.3        Middle East and Africa Neurological Biomarker Market – By End User

1.3.4        Middle East and Africa Neurological Biomarker Market – By Country

2.           Neurological Biomarker Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Neurological Biomarker Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Middle East and Africa – PEST Analysis

4.3         Expert Opinion

5.           Neurological Biomarker Market – Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Rising Prevalence of Neurological Diseases

5.1.2        Growing Focus on Neurological Biomarker Research

5.2         Key Market Restraints

5.2.1        Concerns Associated with Biomarkers

5.3         Key Market Opportunities

5.3.1        Increasing Awareness of Neurological Diseases Coupled with Developing Healthcare Infrastructure

5.4         Future Trends

5.4.1        The Rising Trend of Precision/Personalized Healthcare

5.5         Impact analysis

6.           Neurological Biomarker Market – Middle East and Africa Analysis

6.1         Middle East and Africa Neurological Biomarker Market Revenue Forecast and Analysis

7.           Neurological Biomarker Market Analysis– by Product

7.1         Overview

7.2         Neurological Biomarker Market Share, By Product, 2019 & 2027 (%)

7.3         Proteomics Biomarker

7.3.1        Overview

7.3.2        Proteomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

7.4         Genomics Biomarker

7.4.1        Overview

7.4.2        Genomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

7.5         Metabolomics Biomarker

7.5.1        Overview

7.5.2        Metabolomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

7.6         Imaging Biomarker

7.6.1        Overview

7.6.2        Imaging Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

7.7         Others

7.7.1        Overview

7.7.2        Others Market Revenue and Forecasts to 2027 (US$ Mn)

8.           Neurological Biomarker Market Analysis– by Application

8.1         Overview

8.2         Neurological Biomarker Market Share, By Application, 2019 & 2027 (%)

8.3         Alzheimer’s Disease

8.3.1        Overview

8.3.2        Alzheimer’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.4         Parkinson’s Disease

8.4.1        Overview

8.4.2        Parkinson’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.5         Schizophrenia

8.5.1        Overview

8.5.2        Schizophrenia Market Revenue and Forecasts to 2027 (US$ Mn)

8.6         Huntington's Disease

8.6.1        Overview

8.6.2        Huntington's Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.7         Spinal Muscular Atrophy

8.7.1        Overview

8.7.2        Spinal Muscular Atrophy Market Revenue and Forecasts to 2027 (US$ Mn)

8.8         Others

8.8.1        Overview

8.8.2        Others Market Revenue and Forecasts to 2027 (US$ Mn)

9.           Neurological Biomarker Market Analysis– by End User

9.1         Overview

9.2         Neurological Biomarker Market Share, By End User, 2019 & 2027 (%)

9.3         Pharmaceutical and Biotechnology Companies

9.3.1        Overview

9.3.2        Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)

9.4         Clinical Diagnostics

9.4.1        Overview

9.4.2        Clinical Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

9.5         Research Organizations

9.5.1        Overview

9.5.2        Research Organizations Market Revenue and Forecasts to 2027 (US$ Mn)

10.        Neurological Biomarker Market Analysis and Forecasts To 2027 – Geographical Analysis

10.1      Middle East and Africa: Neurological Biomarker Market

10.1.1     Overview

10.1.2     Middle East and Africa: Neurological Biomarker Market- Revenue and Forecast to 2027 (USD Million)

10.1.3     Middle East and Africa: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.4     Middle East and Africa: Neurological Biomarker Market, by Application, 2018–2027 (Million Units)

10.1.5     Middle East and Africa: Neurological Biomarker, Market, by End User, 2018–2027 (USD Million)

10.1.6     Middle East and Africa: Neurological Biomarker Market, by Country, 2019 & 2027 (%)

10.1.7     Saudi Arabia: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)

10.1.7.1       Saudi Arabia: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)

10.1.7.2       Saudi Arabia: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.7.3       Saudi Arabia: Neurological Biomarker Market, by Application, 2018–2027 (Million Units)

10.1.7.4       Saudi Arabia: Neurological Biomarker, Market, by End User, 2018–2027 (USD Million)

10.1.8     UAE: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)

10.1.8.1       UAE: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)

10.1.8.2       UAE: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.8.3       UAE: Neurological Biomarker Market, by Application, 2018–2027 (Million Units)

10.1.8.4       UAE: Neurological Biomarker, Market, by End User, 2018–2027 (USD Million)

10.1.9     South Africa: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)

10.1.9.1       South Africa: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)

10.1.9.2       South Africa: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.9.3       South Africa: Neurological Biomarker Market, by Application, 2018–2027 (Million Units)

10.1.9.4       South Africa: Neurological Biomarker, Market, by End User, 2018–2027 (USD Million)

11.        Impact of COVID-19 Pandemic on Middle East and Africa Neurological Biomarker Market

11.1      Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12.        Company Profiles

12.1      Thermo Fisher Scientific Inc.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Abbott

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Bio-Rad Laboratories Inc.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      QIAGEN

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Immunarray Pvt. Ltd.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Quest Diagnostics Incorporated

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Perkin Elmer, Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      MERCK KGaA

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

13.        Appendix

13.1      Glossary of Terms

LIST OF TABLES

Table 1.             Middle East and Africa Neurological Biomarker Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 2.             Middle East and Africa Neurological Biomarker Market, by Application– Volume and Forecast to 2027 (Million Units)

Table 3.             Middle East and Africa Neurological Biomarker Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 4.             Saudi Arabia Neurological Biomarker Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 5.             Saudi Arabia Neurological Biomarker Market, by Application– Volume and Forecast to 2027 (Million Units)

Table 6.             Saudi Arabia Neurological Biomarker Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7.             UAE Neurological Biomarker Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 8.             UAE Neurological Biomarker Market, by Application– Volume and Forecast to 2027 (Million Units)

Table 9.             UAE Neurological Biomarker Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 10.          South Africa Neurological Biomarker Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 11.          South Africa Neurological Biomarker Market, by Application– Volume and Forecast to 2027 (Million Units)

Table 12.          South Africa Neurological Biomarker Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 13.          Glossary of Terms, Neurological Biomarker Market

LIST OF FIGURES

Figure 1.           Neurological Biomarker Market Segmentation

Figure 2.           Neurological Biomarker Market – By Country

Figure 3.           Middle East and Africa Neurological Biomarker Market Overview

Figure 4.           Genomic Biomarkers Segment Held Largest Share of Neurological Biomarker Market

Figure 5.           Middle East and Africa Neurological Biomarker Market- Leading Country Markets (US$ Million)

Figure 6.           Middle East and Africa PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           Neurological Biomarker Market Impact Analysis of Driver and Restraint

Figure 9.           Middle East and Africa Neurological Biomarker Market – Revenue Forecast and Analysis – 2019- 2027

Figure 10.        Neurological Biomarker Market Share, by Product, 2019 & 2027 (%)

Figure 11.        Proteomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        Genomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        Metabolomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.        Imaging Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        Neurological Biomarker Market Share, by Application, 2019 & 2027 (%)

Figure 17.        Alzheimer’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        Parkinson’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        Schizophrenia Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.        Huntington's Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        Spinal Muscular Atrophy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.        Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.        Neurological Biomarker Market Share, by End User, 2019 & 2027 (%)

Figure 24.        Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.        Clinical Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.        Research Organizations Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27.        Middle East and Africa: Neurological Biomarker Market, by Key Country – Revenue (2019) (USD Million)

Figure 28.        Middle East and Africa Neurological Biomarker Market Revenue and Forecast to 2027 (USD Million)

Figure 29.        Middle East and Africa: Neurological Biomarker Market, by Country, 2019 & 2027 (%)

Figure 30.        Saudi Arabia: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)

Figure 31.        UAE: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)

Figure 32.        South Africa: Neurological Biomarker Market– Revenue and Forecast to 2027 (USD Million)

Figure 33.           Impact of COVID-19 Pandemic in Middle East and Africa Countries Market